Idenix Pharmaceuticals Inc. (IDIX) Management Discusses Q2 2013 Results (Webcast)

Aug. 7.13 | About: Idenix Pharmaceuticals, (IDIX)

Idenix (IDIX): Q2 EPS of -$0.22 beats by $0.01. Revenue of $112K misses by $58K. (PR)

The following audio is from an earnings conference call that will begin on August 7, 2013, at 8:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.